相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Meta-analysis of biomarkers predicting risk of malignant progression in Barrett's oesophagus
K. Altaf et al.
BRITISH JOURNAL OF SURGERY (2017)
Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia
Bela Horvath et al.
GASTROENTEROLOGY REPORT (2016)
Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance A multicenter case-control study
Sophie H. van Olphen et al.
MEDICINE (2016)
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance
Elena Lastraioli et al.
ONCOTARGET (2016)
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
Rebecca C. Fitzgerald et al.
GUT (2014)
Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
Florine Kastelein et al.
GUT (2013)
Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus
Elizabeth L. Bird-Lieberman et al.
GASTROENTEROLOGY (2012)
Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's Esophagus
Helen G. Coleman et al.
GASTROENTEROLOGY (2012)
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Tusar K. Desai et al.
GUT (2012)
The Incidence of Esophageal Adenocarcinoma in Barrett's Esophagus Has Been Overestimated
Tusar K. Desai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma
Sachin Wani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett's Esophagus
F. Kastelein et al.
DIGESTIVE DISEASES (2011)
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Stuart J. Spechler et al.
GASTROENTEROLOGY (2011)
Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study
Shivaram Bhat et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Incidence of Adenocarcinoma among Patients with Barrett's Esophagus
Frederik Hvid-Jensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Low-Grade Dysplasia in Barrett's Esophagus: Overdiagnosed and Underestimated
Wouter L. Curvers et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Marjolein Sikkema et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
How Many Studies Do You Need? A Primer on Statistical Power for Meta-Analysis
Jeffrey C. Valentine et al.
JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS (2010)
Receipt of Previous Diagnoses and Endoscopy and Outcome From Esophageal Adenocarcinoma: A Population-Based Study With Temporal Trends
Gregory S. Cooper et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case-Control Study
Marjolein Sikkema et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: A systematic review and meta-analysis
Fouad Yousef et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Kenneth K. Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans
Joel H. Rubenstein et al.
GASTROINTESTINAL ENDOSCOPY (2008)
Grading of dysplasia in Barrett's oesophagus:: substantial interobserver variation between general and gastrointestinal pathologists
M. Kerkhof et al.
HISTOPATHOLOGY (2007)
Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance
Pierre Lao-Sirieix et al.
CLINICAL CANCER RESEARCH (2007)
hERG1 channels in human esophagus: Evidence for their aberrant expression in the malignant progression of Barrett's esophagus
Elena Lastraioli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort
L. Murray et al.
GUT (2006)
Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer
A Fountoulakis et al.
BRITISH JOURNAL OF SURGERY (2004)
Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years
M Hage et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Mechanisms of Disease: carcinogenesis in Barrett's esophagus
Navtej S. Buttar et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression
AP Weston et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Prospective study of cyclin D1 overexpression in Barrett's esophagus: Association with increased risk of adenocarcinoma
K Bani-Hani et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
